Refine Search

New Search

Result: 1

(searched for: 10.29328/journal.ijceo.1001034)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
, Mercan Kadir, Demir Nesrin, Ilhan Nevin, Çatak Onur
International Journal of Clinical and Experimental Ophthalmology, Volume 5, pp 001-004; https://doi.org/10.29328/journal.ijceo.1001034

Abstract:
Purpose: To evaluate the levels of salusin-beta (β-SAL) in the serum in patients with age-related macular degeneration (ARMD). Methods: Our study was designed as a controlled comparative clinical study. The β-SAL levels in serums of age and sex-matched 20 healthy volunteers as controls (Group 1), 20 patients with dry-age related macular degeneration (d-ARMD) (Group 2) and 20 patients with wet-age related macular degeneration (w-ARMD) (Group 3) were measured with the enzyme-linked immunosorbent assay (ELISA) method. Results: In our study, it was found that age and gender didn’t show a statistically significant difference among the study groups (p > 0. 05). The mean serum β-SAL levels in Group 1, Group 2 and Group 3 were 1372,17 ± 1126.69 pg/mL; 1423,71 ± 1196.84 pg/mL and 940,57 ± 1092.05 pg/mL, respectively. Although the meanβ-SAL levels in w-ARMD seem numerically lower than both the control and d-ARMD groups, this difference among the study groups was not statistically significant (p > 0.05). Conclusion: Our study suggests that β-SAL levels in the patients with ARMD and healthy controls were not different than each other. Further studies with large numbers may reveal possible relationships between β-SAL and ARMD.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top